Cullinan Therapeutics Q2 Operating Income USD -57.254 Million Vs. IBES Estimate USD -57.1 Million
CGEM•Q2 results and operating expenses
Aug. 6 (Reuters) - Cullinan Therapeutics Q2 net income was USD -53.704 million.
- Q2 operating expenses were USD 57.254 million
- Q2 cash & investments were USD 356 million
